← Back to STLN

Starling Oncology, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Sep 2025Filed 13/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026Dec 2024Filed 26/03/2025Sep 2024Filed 13/11/2025Jun 2024Filed 13/11/2025
$161$147$137$120$104$100$99
−$9.8−$2.5−$17−$17−$20−$16−$15
−$0.08−$0.02−$0.14−$0.15−$0.21−$0.18−$0.17
1031029793777675

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.